CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Contineum Therapeutics (CTNM) was downgraded by Wall Street Zen from
Contineum Therapeutics (CTNM) had its price target raised by Robert W. Baird from $14.00 to $20.00. They now have an "outperform" rating on the stock.
Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones [Yahoo! Finance]
Form S-8 Contineum Therapeutics,
Form 424B5 Contineum Therapeutics,
Form 10-K Contineum Therapeutics, For: Dec 31
Form 8-K Contineum Therapeutics, For: Mar 05
Form 4 Contineum Therapeutics, For: Mar 02 Filed by: Lorrain Daniel S.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.